April 30, 2023
1 min read
Save
VySpine receives FDA 510(k) clearance of intervertebral body fusion system
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- VySpine received FDA clearance of the UniVy OsteoVy-Ti NanoVy-HA cervical intervertebral body fusion system.
- The system is indicated for patients undergoing fusion at one level in the cervical spine.
VySpine has announced FDA 510(k) clearance of its UniVy OsteoVy-Ti NanoVy-HA cervical intervertebral body fusion system, according to a press release.
The UniVy OsteoVy-Ti NanoVy-HA cervical intervertebral body fusion (IBF) system is indicated for patients with degenerative disc disease who undergo IBF at one level in the cervical spine. According to the release, the system is designed with a range of sizes, heights and lordotic angles to promote bone integration and tissue regeneration.